Credit: REUTERS/STEPHEN LAMAug 28 (Reuters) - Gilead Inc GILD.O said on Friday the U.S. Food and Drug Administration has authorized expanded emergency use for its experimental antiviral COVID-19 treatment, remdesivir.
The drug can now be used to treat all hospitalized patients with COVID-19, in addition to patients with a severe form of the illness. (https://reut.rs/31DfMIk)
(Reporting By Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)
((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 806749 8325;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
